IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2026 Holdings

Filed 2026-08-14 | 10 holdings | $177.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$42.9M1,890,60424.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$38.7M9,188,63521.7%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$26.7M1,673,39515.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$19.6M116,53311.0%
Cytokinetics Inc(CYTK)COM NEW23282W605$19.5M228,62310.9%
Lantheus Hldgs Inc(LNTH)COM516544103$18.5M166,91910.4%
Biohaven LTD(BHVN)COMG1110E107$8.7M582,3124.9%
Regeneron Pharmaceuticals(REGN)COM75886F107$2.6M4,1901.5%
VOR Biopharma Inc(VOR)COM NEW929033207$467.6K25,3990.3%
Biogen Inc(BIIB)COM09062X103$205.3K9500.1%